Results 231 to 240 of about 109,434 (328)

Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Mastocytosis is categorized into cutaneous mastocytosis (CM), mast cell sarcoma and systemic mastocytosis (SM). Within SM, indolent SM (ISM) is the more frequent subtype. Adult patients with CM but without an extracutaneous biopsy are classified as having mastocytosis in the skin (MIS), a provisional diagnosis.
Julien Rossignol   +15 more
wiley   +1 more source

Age‐Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators

open access: yes
Allergy, EarlyView.
Daniel Brigger   +6 more
wiley   +1 more source

Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol—A prospective study

open access: yesBritish Journal of Haematology, EarlyView.
In this population‐based study the relapse rates were remarkably low in patients reaching day 79 with active treatment, challenging the widely accepted belief that ALL is difficult to cure in the elderly. Summary Population data have shown that the prognosis for elderly patients with acute lymphoblastic leukaemia (ALL) is poor, even in the modern era ...
P. Quist‐Paulsen   +8 more
wiley   +1 more source

Adrenaline nasal spray in emergency management: An initial expert opinion. [PDF]

open access: yesAllergol Select
Treudler R   +7 more
europepmc   +1 more source

Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited‐Stage Small‐Cell Lung Cancer in the Phase 3 ADRIATIC Trial

open access: yesCancer Science, EarlyView.
This Japan subgroup analysis of the global phase 3 ADRIATIC trial showed that consolidation durvalumab versus placebo improves outcomes, and is well tolerated, in patients with limited‐stage small‐cell lung cancer following concurrent chemoradiotherapy comprising cisplatin or carboplatin‐based chemotherapy and once‐daily or twice‐daily radiotherapy ...
Yoshitaka Zenke   +14 more
wiley   +1 more source

Hypofibrinogenemia Following an Anaphylactic Shock Caused by a Neuromuscular Blocking Agent-Case Report. [PDF]

open access: yesCase Rep Crit Care
Iarossi M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy